Vascular targeted therapies for fibrotic lung disease: start of a new era?

Shareable abstract The vasculature in lungs with pulmonary fibrosis shows signs of vasculopathy independent of hemodynamic PH-ILD. This viewpoint briefly summarizes the evidence that vasculopathy can drive fibrosis progression and that targeting it is highly promising